Although abundant feedback and parallel signalling pathways can limit the efficacy of this compound or the value of the targets, such as FGFs, FGFRs and Src, additional studies are needed to develop a successful strategy for treating patients with PF. Here, SRC is linked to pemphigus foliaceus.